Cargando…
Recombinant Thrombopoietin Effectively Shortens the Time to Response and Increases Platelet Counts in Elderly Patients with Severe Immune Thrombocytopenia
Background: This study was conducted to investigate the short-term efficacy and safety of rhTPO for the management of severe ITP in the elderly as first-line treatment. Methods: A total of 54 elderly patients with severe ITP were studied, including 39 patients treated with a combination regimen of r...
Autores principales: | Li, Yang, Sun, Lihua, Li, Feng, Li, Ying, Hou, Yunhua, Meng, Yahong, Fan, Xiaohong, Cheng, Yunfeng, Hua, Fanli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573713/ https://www.ncbi.nlm.nih.gov/pubmed/36233631 http://dx.doi.org/10.3390/jcm11195763 |
Ejemplares similares
-
Thrombopoietin levels in Quebec platelet disorder—Implications for the mechanism of thrombocytopenia
por: Hayward, C. P. M., et al.
Publicado: (2018) -
A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response
por: Oberoi, Gurleen, et al.
Publicado: (2022) -
Thrombopoietin: a potential diagnostic indicator of immune thrombocytopenia in pregnancy
por: Zhang, Xu, et al.
Publicado: (2016) -
A Network Meta-Analysis of Two Doses of Recombinant Human Thrombopoietin for Treating Sepsis-Related Thrombocytopenia
por: Chen, Dandan, et al.
Publicado: (2022) -
P1666: EFFECT OF AGONISTS TO THROMBOPOIETIN RECEPTORS ON PLATELET GLYCOME OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA
por: Monzón Manzano, E., et al.
Publicado: (2022)